OH-Chol |
A cationic cholesterol derivative; has been used in lipoplexes with DOPE f… |
10 mg |
26586-10 |
More Info
|
OH-Chol |
A cationic cholesterol derivative; has been used in lipoplexes with DOPE f… |
25 mg |
26586-25 |
More Info
|
OH-Chol |
A cationic cholesterol derivative; has been used in lipoplexes with DOPE f… |
5 mg |
26586-5 |
More Info
|
6-OHDA (hydrobromide) |
A catecholaminergic neurotoxin; has been used to induce dopaminergic lesio… |
1 g |
25330-1 |
More Info
|
6-OHDA (hydrobromide) |
A catecholaminergic neurotoxin; has been used to induce dopaminergic lesio… |
250 mg |
25330-250 |
More Info
|
6-OHDA (hydrobromide) |
A catecholaminergic neurotoxin; has been used to induce dopaminergic lesio… |
50 mg |
25330-50 |
More Info
|
1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-PC |
The product of acylation of lyso-PAF C-16 |
1 mg |
60904-1 |
More Info
|
1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-PC |
The product of acylation of lyso-PAF C-16 |
10 mg |
60904-10 |
More Info
|
1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-PC |
The product of acylation of lyso-PAF C-16 |
25 mg |
60904-25 |
More Info
|
1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-PC |
The product of acylation of lyso-PAF C-16 |
5 mg |
60904-5 |
More Info
|
1-O-hexadecyl-2-Dihomo-γ-Linolenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Dihomo-γ-linolenoyl-sn-glycero-3-PC is a PAF analog… |
1 mg |
60901-1 |
More Info
|
1-O-hexadecyl-2-Dihomo-γ-Linolenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Dihomo-γ-linolenoyl-sn-glycero-3-PC is a PAF analog… |
10 mg |
60901-10 |
More Info
|
1-O-hexadecyl-2-Dihomo-γ-Linolenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Dihomo-γ-linolenoyl-sn-glycero-3-PC is a PAF analog… |
25 mg |
60901-25 |
More Info
|
1-O-hexadecyl-2-Dihomo-γ-Linolenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Dihomo-γ-linolenoyl-sn-glycero-3-PC is a PAF analog… |
5 mg |
60901-5 |
More Info
|
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC is a PAF analog which cont… |
1 mg |
60903-1 |
More Info
|
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC is a PAF analog which cont… |
10 mg |
60903-10 |
More Info
|
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC is a PAF analog which cont… |
25 mg |
60903-25 |
More Info
|
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC |
1-O-hexadecyl-2-Docosahexaenoyl-sn-glycero-3-PC is a PAF analog which cont… |
5 mg |
60903-5 |
More Info
|
1-O-hexadecyl-2-Eicosapentaenoyl-sn-glycero-3-PC |
Can be formed by incorporation of EPA into lyso-PAF C-16, as has been demo… |
1 mg |
60907-1 |
More Info
|
1-O-hexadecyl-2-Eicosapentaenoyl-sn-glycero-3-PC |
Can be formed by incorporation of EPA into lyso-PAF C-16, as has been demo… |
10 mg |
60907-10 |
More Info
|
1-O-hexadecyl-2-Eicosapentaenoyl-sn-glycero-3-PC |
Can be formed by incorporation of EPA into lyso-PAF C-16, as has been demo… |
5 mg |
60907-5 |
More Info
|
2-O-Hexadecyl Glycerol |
A β-monoglyceride of palmitic acid |
1 mg |
11924-1 |
More Info
|
2-O-Hexadecyl Glycerol |
A β-monoglyceride of palmitic acid |
10 mg |
11924-10 |
More Info
|
2-O-Hexadecyl Glycerol |
A β-monoglyceride of palmitic acid |
25 mg |
11924-25 |
More Info
|
2-O-Hexadecyl Glycerol |
A β-monoglyceride of palmitic acid |
5 mg |
11924-5 |
More Info
|
1-O-Hexadecyl-sn-glycerol |
An alkyl glyceryl ether; reduces UVB-induced cell death and production of… |
1 g |
25723-1 |
More Info
|
1-O-Hexadecyl-sn-glycerol |
An alkyl glyceryl ether; reduces UVB-induced cell death and production of… |
100 mg |
25723-100 |
More Info
|
1-O-Hexadecyl-sn-glycerol |
An alkyl glyceryl ether; reduces UVB-induced cell death and production of… |
250 mg |
25723-250 |
More Info
|
1-O-Hexadecyl-sn-glycerol |
An alkyl glyceryl ether; reduces UVB-induced cell death and production of… |
500 mg |
25723-500 |
More Info
|
O-2545 (hydrochloride) |
A potent water-soluble agonist of CB1 and CB2 receptors with Ki values of… |
1 mg |
10009195-1 |
More Info
|
O-2545 (hydrochloride) |
A potent water-soluble agonist of CB1 and CB2 receptors with Ki values of… |
10 mg |
10009195-10 |
More Info
|
O-2545 (hydrochloride) |
A potent water-soluble agonist of CB1 and CB2 receptors with Ki values of… |
5 mg |
10009195-5 |
More Info
|
O-2545 (hydrochloride) |
A potent water-soluble agonist of CB1 and CB2 receptors with Ki values of… |
500 µg |
10009195-500 |
More Info
|
306Oi10 |
A branched-chain ionizable cationic lipidoid; has been used in the generat… |
10 mg |
36698-10 |
More Info
|
306Oi10 |
A branched-chain ionizable cationic lipidoid; has been used in the generat… |
25 mg |
36698-25 |
More Info
|
306Oi10 |
A branched-chain ionizable cationic lipidoid; has been used in the generat… |
5 mg |
36698-5 |
More Info
|
O4I1 |
An inducer of Oct3 / 4 expression and translation in human cell lines and… |
10 mg |
19935-10 |
More Info
|
O4I1 |
An inducer of Oct3 / 4 expression and translation in human cell lines and… |
25 mg |
19935-25 |
More Info
|
O4I1 |
An inducer of Oct3 / 4 expression and translation in human cell lines and… |
5 mg |
19935-5 |
More Info
|
O4I1 |
An inducer of Oct3 / 4 expression and translation in human cell lines and… |
50 mg |
19935-50 |
More Info
|
O4I2 |
A potent inducer of Oct3 / 4 expression and translation in human cell line… |
1 mg |
19135-1 |
More Info
|
O4I2 |
A potent inducer of Oct3 / 4 expression and translation in human cell line… |
10 mg |
19135-10 |
More Info
|
O4I2 |
A potent inducer of Oct3 / 4 expression and translation in human cell line… |
25 mg |
19135-25 |
More Info
|
O4I2 |
A potent inducer of Oct3 / 4 expression and translation in human cell line… |
5 mg |
19135-5 |
More Info
|
306Oi9-cis2 |
An ionizable cationic lipid |
1 mg |
39557-1 |
More Info
|
306Oi9-cis2 |
An ionizable cationic lipid |
10 mg |
39557-10 |
More Info
|
306Oi9-cis2 |
An ionizable cationic lipid |
25 mg |
39557-25 |
More Info
|
306Oi9-cis2 |
An ionizable cationic lipid |
5 mg |
39557-5 |
More Info
|
OICR-9429 |
A selective inhibitor of the interaction of WDR5 with peptide regions of M… |
1 mg |
16095-1 |
More Info
|
OICR-9429 |
A selective inhibitor of the interaction of WDR5 with peptide regions of M… |
10 mg |
16095-10 |
More Info
|